Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Not yet recruiting × Aminolevulinic Acid × Clear all

Phase

Phase 2 2 Phase EARLY_PHASE1 1

Status

Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

fludarabine 5 Cyclophosphamide 5 Standard of Care 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 Biopsy 2 Bevacizumab 2 venetoclax 1 tucatinib 1 trifluridine tipiracil drug combination 1 tremelimumab 1 trastuzumab deruxtecan 1 tislelizumab 1 tipiracil 1 spartalizumab 1 sotorasib 1 selpercatinib 1 posaconazole 1 perflutren 1 pembrolizumab 1 osimertinib 1 montelukast 1 malic acid 1 icotinib 1 encorafenib 1 eliglustat 1 durvalumab 1 daratumumab 1 asciminib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038278 2026-02-27

5-ALARMS

University of Colorado, Denver

Phase EARLY_PHASE1 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡